MedTrace Logo

Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 mcg BID

NCT00235053 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2024-01-30

No results posted yet for this study

Summary

This Pilot study is designed to explore the rate of local side effects of fluticasone as delivered by Advair and to determine the best outcome measure to assess these effects. This study is the initial step, and will be followed by a larger scale study.

Conditions

  • Asthma
  • Candidiasis, Oral
  • Voice Disorders

Interventions

DRUG

fluticasone/salmeterol DISKUS 250/50

Sponsors & Collaborators

  • Allergy & Asthma Medical Group & Research Center

    lead OTHER

Principal Investigators

  • Eli O Meltzer, MD · Allergy & Asthma Medical Group & Research Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-08-31
Completion
2005-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00235053 on ClinicalTrials.gov